Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
Open Access
- 29 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8), e38286
- https://doi.org/10.1371/journal.pone.0038286
Abstract
Besides well-established roles of bile acids (BA) in dietary lipid absorption and cholesterol homeostasis, it has recently become clear that BA is also a biological signaling molecule. We have shown that strategies aimed at activating TGR5 by increasing the BA pool size with BA administration may constitute a significant therapeutic advance to combat the metabolic syndrome and suggest that such strategies are worth testing in a clinical setting. Bile acid binding resin (BABR) is known not only to reduce serum cholesterol levels but also to improve glucose tolerance and insulin resistance in animal models and humans. However, the mechanisms by which BABR affects glucose homeostasis have not been established. We investigated how BABR affects glycemic control in diet-induced obesity models. We evaluated the metabolic effect of BABR by administrating colestimide to animal models for the metabolic syndrome. Administration of BABR increased energy expenditure, translating into significant weight reduction and insulin sensitization. The metabolic effects of BABR coincide with activation of cholesterol and BA synthesis in liver and thermogenesis in brown adipose tissue. Interestingly, these effects of BABR occur despite normal food intake and triglyceride absorption. Administration of BABR and BA had similar effects on BA composition and thermogenesis, suggesting that they both are mediated via TGR5 activation. Our data hence suggest that BABR could be useful for the management of the impaired glucose tolerance of the metabolic syndrome, since they not only lower cholesterol levels, but also reduce obesity and improve insulin resistance.This publication has 48 references indexed in Scilit:
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy ExpenditureJournal of Biological Chemistry, 2011
- Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of ObesityDiabetes, 2011
- Plasma bile acids are not associated with energy metabolism in humansNutrition & Metabolism, 2010
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Cold-Activated Brown Adipose Tissue in Healthy MenThe New England Journal of Medicine, 2009
- Identification and Importance of Brown Adipose Tissue in Adult HumansThe New England Journal of Medicine, 2009
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With MetforminArchives of Internal Medicine, 2008
- Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based TherapyDiabetes Care, 2008
- Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1Molecular and Cellular Biology, 2007
- The Enzymes, Regulation, and Genetics of Bile Acid SynthesisAnnual Review of Biochemistry, 2003